title: Serum selenium deficiency in patients with hematological malignancies: is a supplementation study mandatory?
authors.forename: Ralph
authors.initials: R
authors.lastname: Muecke
authors.forename: Oliver
authors.initials: O
authors.lastname: Micke
authors.forename: Lutz
authors.initials: L
authors.lastname: Schomburg
authors.forename: Jens
authors.initials: J
authors.lastname: Buentzel
authors.forename: Irenaeus A
authors.initials: IA
authors.lastname: Adamietz
authors.forename: Jutta
authors.initials: J
authors.lastname: Huebner
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019587:Dietary Supplements; D005260:Female; D019337:Hematologic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012643:Selenium / Q000097:blood / Q000172:deficiency*; D013054:Spectrophotometry, Atomic
chemical_list: D012643:Selenium